Monograph Details
|
|
Neoplasms
> Hormones and antagonists
|
|
TRELSTAR LA |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
GnRH analogue. |
| Generic Name |
|
Triptorelin pamoate 11.25mg; pwd for IM inj after reconstitution. |
| Also |
|
• TRELSTAR DEPOT
|
| Indications |
|
Palliative treatment of advanced prostate cancer. |
| Children |
Not applicable.
|
| Adults |
|
Give by IM inj in buttock. 11.25mg every 84 days. |
| Contraindications |
|
Pregnancy (Cat.X). Nursing mothers. |
| Precautions |
|
Discontinue if hypersensitivity occurs. Initial transient increase in serum testosterone may result in worsening of symptoms. Spinal cord compression. Renal impairment. Metastatic vertebral lesions. Upper or lower urinary tract obstruction. |
| Interactions |
|
Avoid hyperprolactinemic drugs. |
| Adverse Reactions |
|
Inj site reactions, hot flushes, bone pain, fatigue, hypertension, headache, dizziness, GI upset, leg edema, insomnia, impotence, emotional lability, anemia, pruritus, urinary retention, UTI. |
| How Supplied |
Single-dose vial—1
Clip 'n' Ject delivery system—1 (single-dose vial + prefilled syringe) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
